WASHINGTON - In an effort to increase the availability of testing for COVID-19, the U.S. government has awarded a $231.8 million contract to an Australian company behind the first fully at-home rapid ...
Aug. 10—Five months after the Australian-based biopharmaceutical company Ellume opened its first U.S. location in Frederick, the facility is scaling up its production of at-home COVID-19 tests by ...
New White House initiative provides Ellume COVID-19 Home Tests, which offer enhanced accessibility for people who are blind or have low vision, at no cost to Americans across the country. Consumers ...
A class action complaint was filed against Ellume USA LLC after the company recalled millions of at-home COVID-19 test kits last year. The complaint alleges Ellume is "unjustly retaining the monies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results